Future Science Group

In light of the upcoming Regenerative Medicine Special Focus Issue on immunological challenges and opportunities in regenerative medicine, RegMedNet conducted an interview with Professor Paul Fairchild, Guest Editor of the issue. This interview on immunology within the field of regenerative medicine provides a great insight into the interface between stem cell biology and immunology – to bring cel...

As the field of 3D printing grows, we are seeing it put to an increasing number of uses in medicine. The technology has been successfully employed to create a number of scaffolds and implants, as well as to generate personalized anatomical models to be used for surgical planning and patient education. Recently, the field has expanded to include the generation of 3D antenatal models. Generated from...

In recent years, we have seen 3D printing put to an ever-expanding range of uses in the medical field. Products printed with manmade materials include implants, scaffolds, anatomical models and personalized devices and masks. In addition, the area of bioprinting has begun to expand, with researchers now printing live cells in order to encourage regeneration and create tissues and organs. Now, the...

In the third and final part of our panel discussion, we discuss the growing skills gap in bioanalytical laboratories including: Reality of the skills gap In which technical areas is the skills gap most apparent? Where does the skills gap occur – Pharma and / or CROs? How do we bridge the gap?

In part 2 of this panel discussion, the panelists discuss the divide between investments being made by Pharma and CROs in new bioanalytical techniques and technologies. Discussions include: Investments made by Pharma and CROs for new constructs Is there a real divide between CRO and Pharma? If so, why is this occurring? What are the gaps? What are the solutions?

This year Bioanalysis Zone and Bioanalysis attended the 10th WRIB meeting in Florida (USA), where we organized a panel discussion* comprising experts from leading CROs and pharmaceutical companies to assess the current situation and future opportunities in bioanalysis. To have leading CRO and Pharmaceutical directors’ talk candidly about the key business challenges in bioanalysis is a rare occasio...

In this exceptional open dialogue held earlier this year at the 10th WRIB meeting in Orlando (FL, USA), our panel of experts discuss some of the fundamental questions raised with respect to outsourcing in regulated bioanalysis. In part 1 of this panel discussion, a panel of leading CRO and Pharma Directors assess the current situation of outsourcing in bioanalysis, and discuss the direction of out...

In this NCTalks podcast, Alice Weatherston speaks to Lance McCracken, Professor of Behavioral Medicine at King’s College London (UK), about the use of psychological therapies in pain management. In Part 2, we speak to Lance about his work in Acceptance and Commitment Therapy, and his outlook for the future of behavioral therapies in pain management. Summary - A lot of your work has focused on Acce...

In this NCTalks podcast, Alice Weatherston speaks to Lance McCracken, Professor of Behavioral Medicine at King’s College London (UK), about the use of psychological therapies in pain management. In Part 1, Lance outlines the role psychological therapies in chronic pain management and the general attitudes and approaches to such therapies across the medical community. Summary - What are your curren...

In this NCtalks podcast, we speak to Michael Merzenich, a leading professor in neuroplasticity at the University of California, San Francisco (USA), whose team was recently involved in a longitudinal trial into the effect of brain training on cognitive decline and dementia.

In this NCtalks podcast, we speak to Hance Clarke, Director of Pain Services and the Medical Director of the Pain Research Unit at the Toronto General Hospital (ON, Canada).

In this edition of NCtalks, we speak to Michael Merzenich, renowned professor in neuroplasticity.

NCTalks with Michael Merzenich - understanding brain plasticity by Taylor & Francis Group

BZTalks: David Griffiths (LGC) on mergers & acquisitions in the bioanalytical field by Taylor & Francis Group

BZTalks: Interview with Steven Carr (Broad Institute) on proteomics for personalized medicine by Taylor & Francis Group

BZTalks: Chris Beaver (inVentiv Health) on free vs total assays by Taylor & Francis Group